Insulin Analogs

Insulin analogs are man-made versions of human insulin designed to help regulate blood sugar levels in people with diabetes. They are designed to mimic the body's natural insulin response but offer advantages like faster absorption, longer action, and more predictable glucose control. There are two main types of insulin analogs: rapid-acting (e.g., insulin lispro, aspart) and long-acting (e.g., insulin glargine, detemir). Rapid-acting analogs work quickly to manage blood sugar spikes after meals, while long-acting analogs provide a steady release of insulin over 24 hours. These analogs help reduce the risk of hypoglycemia and improve overall glycemic control, making them a crucial option for people with Type 1 and Type 2 diabetes. Their flexibility allows patients to better tailor insulin regimens to their lifestyle and needs.

Committee Members
Speaker at Diabetes  2026 - Mahir Khalil Ibrahim Jallo

Mahir Khalil Ibrahim Jallo

Gulf Medical University, Canada
Speaker at Diabetes  2026 - F Buck Willis

F Buck Willis

Christian College of Medicine, Belize
Speaker at Diabetes  2026 - Anil Harrison

Anil Harrison

Midwestern University, United States
Speaker at Diabetes  2026 - Wan Rosli Wan Ishak

Wan Rosli Wan Ishak

Universiti Sains Malaysia, Malaysia
Diabetes 2026 Speakers
Speaker at Diabetes  2026 - Mahir Khalil Ibrahim Jallo

Mahir Khalil Ibrahim Jallo

Gulf Medical University, Canada
Speaker at Diabetes  2026 - F Buck Willis

F Buck Willis

Christian College of Medicine, Belize
Speaker at Diabetes  2026 - Anil Harrison

Anil Harrison

Midwestern University, United States
Speaker at Diabetes  2026 - David Navazio

David Navazio

Gentell, United States
Speaker at Diabetes  2026 - Sujith Rajan

Sujith Rajan

NYU Long Island School of Medicine, United States
Speaker at Diabetes  2026 - David Petch

David Petch

utR Biotech, Canada

Submit your abstract Today

YouTube
WhatsAppWhatsApp